Back to Search
Start Over
An efficient GLP-1 expression system using two-step transcription amplification
- Source :
-
Journal of Controlled Release . Oct2006, Vol. 115 Issue 3, p316-321. 6p. - Publication Year :
- 2006
-
Abstract
- Abstract: Glucagon-like peptide 1 (GLP-1) is an insulinotropic protein. It was reported that the continuous infusion of GLP-1 normalized the blood glucose level in type 2 diabetes animal model. However, the short half-life of GLP-1 has limited its application in clinical settings and prompted us to develop a GLP-1 gene therapy system. Our previous results showed that the delivery of pβ-GLP-1 using polyethylenimine (PEI) reduced the blood glucose level effectively. However, the glucose level was not completely normalized. In the present study, the more efficient GLP-1 expression system was developed using two-step transcription amplification (TSTA). To evaluate the TSTA system, pβ-Gal4-p65 and pUAS-Luc were constructed. The pUAS-Luc/pβ-Gal4-p65 system showed the highest transfection efficiency at a 2:1 pUAS-Luc/pβ-Gal4-p65 weight ratio. In addition, the transgene expression by the TSTA system was at least 4 times higher than pβ-Luc. To apply the TSTA system to the GLP-1 expression plasmid, pUAS-GLP-1 was constructed. The pUAS-GLP-1/pβ-Gal4-p65 system showed higher mRNA level than pβ-GLP-1. In addition, the level of GLP-1 by the pUAS-GLP-1/pβ-Gal4-p65 system was more than 4 times higher than pβ-GLP-1. Therefore, the TSTA GLP-1 expression system may be useful to develop gene therapy system for type 2 diabetes. [Copyright &y& Elsevier]
- Subjects :
- *GLUCAGON-like peptide 1
*TYPE 2 diabetes
*PEPTIDE hormones
*PANCREATIC secretions
Subjects
Details
- Language :
- English
- ISSN :
- 01683659
- Volume :
- 115
- Issue :
- 3
- Database :
- Academic Search Index
- Journal :
- Journal of Controlled Release
- Publication Type :
- Academic Journal
- Accession number :
- 22936188
- Full Text :
- https://doi.org/10.1016/j.jconrel.2006.07.017